首页> 外文期刊>Internal medicine. >The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study
【24h】

The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study

机译:日本帕金森氏病的逐渐消失现象的危险因素:横断面,多中心研究

获取原文
           

摘要

Objective Parkinson's disease (PD) is a common, progressive, neurodegenerative disorder. With progression of PD, the wearing-off phenomenon occurs more frequently as a motor complication, decreasing the patient's quality of life. The aim of this study was to investigate the risk factors for the wearing-off phenomenon in Japanese PD patients. Methods All of the study participants were clinically diagnosed as having PD. Each patient was assessed for the wearing-off phenomenon based on the findings of clinical assessments and interviews that were conducted during a single visit. The risk factors for wearing-off were analyzed by univariate and multivariate logistic regression analyses. Results Wearing-off was observed in 101 of the 180 (56.1%) patients who were enrolled in this study. The multivariate logistic regression analysis revealed that the onset of PD at ≥69 years of age (odds ratio [OR], 0.22; 95% confidence interval [CI], 0.05-0.88; p=0.032), female sex (OR, 6.49; 95% CI, 2.34-17.99; p Conclusion Age at the symptomatic disease onset, female sex, COMT inhibitor treatment, and a high daily levodopa dose were associated with the occurrence of wearing-off in Japanese PD patients. Physicians need to consider the risk factors and carefully choose medications for PD patients to postpone the occurrence of this phenomenon for as long as possible.
机译:目的帕金森氏病(PD)是一种常见的进行性神经退行性疾病。随着PD的进展,磨损现象作为运动并发症更频繁地发生,从而降低了患者的生活质量。这项研究的目的是调查日本PD患者的磨损现象的危险因素。方法所有研究参与者均被临床诊断为PD。根据临床评估的结果和单次就诊时的访谈对每位患者的磨损现象进行评估。磨损的危险因素通过单因素和多因素logistic回归分析进行了分析。结果参加本研究的180例患者中有101例(56.1%)观察到磨损。多元logistic回归分析显示,PD≥69岁时发病(几率[OR]为0.22; 95%置信区间[CI]为0.05-0.88; p = 0.032),性别为女性(OR为6.49; 95%CI,2.34-17.99; p结论在日本PD患者中,症状性疾病发作的年龄,女性,COMT抑制剂治疗和每日高左旋多巴剂量与疲倦的发生有关,医生需要考虑这一风险影响因素并仔细选择PD患者的药物,以尽可能长地推迟这种现象的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号